Kenvue, Inc. KVUE 深 滬
等待開盤 01-30 09:30:00 美东时间
17.295
-0.045
-0.26%
華盛通- 最 高17.44
- 今 開17.39
- 成交量 3144.18万股
- 最 低 17.18
- 昨 收 17.34
- 總市值 331.37亿
- 52周最高 24.55
- 市盈率 靜 32.13
- 換手率 1.64%
- 52周最低 13.8125
- 委 比 38.84%
- 總股本 19.16亿
- 歷史最高 25.76
- 量 比 0.71
- 振 幅 1.50%
- 歷史最低 13.8125
- 每 手 1
- 風險率 2.73%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Peering Into Kenvue Inc's Recent Short Interest
Kenvue Inc's (NYSE:KVUE) short interest as a percent of float has risen 18.6% s...
今天 02:00
Kimberly-Clark, Kenvue Shareholders Approve Proposed Acquisition Of Kenvue By Kimberly-Clark; Deal Completion Expected In H2 This Year
Kimberly-Clark Corporation (NASDAQ:KMB) and Kenvue Inc. (NYSE:KVUE) today announced that Kimberly-Clark and Kenvue shareholders voted overwhelmingly to approve all of the proposals necessary for Kimberly-Clark to
01-29 22:34
Kimberly-Clark and Kenvue Shareholders Overwhelmingly Approve Kimberly-Clark's Acquisition of Kenvue
Key Milestone in Creating a Global Health and Wellness Leader Transaction Expected to Close in the Second Half of 2026 DALLAS and SUMMIT, N.J., Jan. 29, 2026 /PRNewswire/ -- Kimberly-Clark C...
01-29 22:27
A Look Into Kenvue Inc's Price Over Earnings
In the current session, Kenvue Inc. (NYSE:KVUE) is trading at $16.69, after a 0...
01-08 03:00
Estée Lauder, Hengan, L’Oréal head the list of top performing personal care stocks YTD
The personal care sector has seen a wide range of performance this year, with some companies delivering impressive returns while others have struggled. Within the sector, only six companies have deli...
2025-12-23 01:44
'Kenvue Faces FDA Petition to Remove Benadryl's Active Ingredient'- Bloomberg
https://www.bloomberg.com/news/articles/2025-12-16/kenvue-faces-fda-petition-to-remove-benadryl-s-active-ingredient
2025-12-17 05:49
Jim Cramer: This Communication Services Stock Is 'Too Speculative'
Jim Cramer said this company is losing money and is "too speculative" for him. The "Mad Money" host recommends this instead.
2025-11-20 21:11
Court Rejects Bid To Block Kenvue's $398 Million Shareholder Payout In Tylenol Safety Dispute
Texas judge rejects bid to block Kenvue's $398 million dividend and declines to restrict Tylenol marketing as the company faces a lawsuit over pregnancy safety claims.
2025-11-18 00:26
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
2025-11-11 10:49
Barclays Maintains Equal-Weight on Kenvue, Raises Price Target to $18
Barclays analyst Lauren Lieberman maintains Kenvue (NYSE:KVUE) with a Equal-Weight and raises the price target from $17 to $18.
2025-11-11 02:47
